Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Edesa Biotech (EDSA) Non Operating Income (2016 - 2022)

Edesa Biotech's Non Operating Income history spans 10 years, with the latest figure at $22400.0 for Q3 2022.

  • For Q3 2022, Non Operating Income fell 98.75% year-over-year to $22400.0; the TTM value through Sep 2022 reached $5.4 million, down 47.86%, while the annual FY2025 figure was $726843.0, 1348.87% up from the prior year.
  • Non Operating Income for Q3 2022 was $22400.0 at Edesa Biotech, up from $10505.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $7.3 million in Q1 2021 and bottomed at -$28065.0 in Q3 2020.
  • The 5-year median for Non Operating Income is $26347.0 (2019), against an average of $933513.6.
  • The largest annual shift saw Non Operating Income plummeted 295.98% in 2020 before it surged 49060.2% in 2021.
  • A 5-year view of Non Operating Income shows it stood at $40892.0 in 2018, then plummeted by 70.29% to $12149.0 in 2019, then tumbled by 295.98% to -$23810.0 in 2020, then soared by 3388.73% to $783046.0 in 2021, then crashed by 97.14% to $22400.0 in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Non Operating Income are $22400.0 (Q3 2022), $10505.0 (Q2 2022), and $4.6 million (Q1 2022).